Class III beta-tubulin expression predicts prostate tumor aggressiveness and patient response to docetaxel-based chemotherapy.
暂无分享,去创建一个
S. Culine | L. Salomon | S. Terry | Y. Allory | A. De la taille | N. Sirab | P. Maillé | P. Soyeux | R. Buttyan | F. Vacherot | G. Ploussard | B. Paule | L. Kheuang | N. Nicolaiew | E. Coppolani